Abbvie Inc. vs Elanco Animal Health Incorporated
ABBV vs ELAN — side-by-side comparison from reported financials. ABBV leads 8, ELAN leads 2 of 10 comparable metrics.
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
Elanco Animal Health Incorporated
ELAN · Healthcare
$22.92+1.69%Mixed
| Metric | ABBV | ELAN |
|---|---|---|
| Price | $276.43 | $22.92 |
| Market cap | $488B | $11.4B |
| Revenue (TTM) | $64.4B | $5.02B |
| Revenue growth | +1.8% | +2.3% |
| Net margin | 9.8% | -4.0% |
| Free cash flow | $18.2B | $379M |
| Net cash (debt) | ($56.2B) | ($3.47B) |
| 1-year price return | +19.8% | +14.2% |
| P/E | 77.4 | — |
| P/E vs own history (cheap-side %) | 23% | 14% |
| Dividend yield | 2.45% | — |
| Return on equity | 96% | -3% |
| Altman Z-score | 2.33 | 1.23 |
| CV checks passed | 9 of 11 | 3 of 11 |
| Employees | 57,000 | 9,900 |
Full résumé-style profiles: ABBV CV · ELAN CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.